Table 1.
Data input | Mean value per income quintile | Range used in sensitivity analysis | ||||
---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q5 | ||
Prior mean salt intake, g/day (Charlton et al. 2005) | 7.8 | 7.9 | 7.9 | 8.0 | 8.6 | 7.3 to 10.5 |
Prior mean SBP, mmHg (SALDRU 2012) | 131.2 | 133.7 | 134.1 | 137.2 | 132.6 | N/A |
Mean SBP change, mmHg | ||||||
Hypertensive individuals (He and MacGregor 2004) | −3.4 | −3.4 | −3.5 | −3.6 | −4.4 | (−2.6) to (−6.6) |
Mean SBP change, mmHg | ||||||
Normotensive individuals (He and MacGregor 2004) | −1.7 | −1.7 | −1.7 | −1.8 | −2.1 | (−0.9) to (−3.9) |
CVD death rate* per 100 000 population (IHME 2013) | ||||||
Stroke | 1646 | 2079 | 1850 | 1823 | 1437 | 959 to 2849 |
IHD | 1106 | 1424 | 1319 | 1310 | 1085 | 723 to 2073 |
HHF | 704 | 881 | 778 | 760 | 591 | 305 to 1460 |
ESRD | 88 | 110 | 104 | 101 | 90 | 51 to 186 |
Average CVD risk reduction achievable by policy (Lewington et al. 2002, Norman et al. 2007) | ||||||
Stroke | 0.08 | 0.08 | 0.08 | 0.09 | 0.10 | 0.02 to 0.19 |
IHD | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | 0.03 to 0.16 |
HHF | 0.16 | 0.16 | 0.16 | 0.18 | 0.19 | 0.09 to 0.33 |
ESRD | 0.16 | 0.16 | 0.16 | 0.18 | 0.18 | 0.09 to 0.33 |
CVD CFR | ||||||
Stroke (Feigin et al. 2009) | 0.266 | 0.266 | 0.266 | 0.266 | 0.266 | 0.180 to 0.350 |
IHD, male (Mathers et al. 2004) | 0.620 | 0.620 | 0.620 | 0.620 | 0.620 | 0.410 to 0.830 |
IHD, female (Mathers et al. 2004) | 0.720 | 0.720 | 0.720 | 0.720 | 0.720 | 0.470 to 0.970 |
HHF (Damasceno et al. 2012) | 0.155 | 0.155 | 0.155 | 0.155 | 0.155 | 0.124 to 0.194 |
ESRD (Ogeng'o et al. 2011) | 0.230 | 0.230 | 0.230 | 0.230 | 0.230 | 0.184 to 0.288 |
SBP, systolic blood pressure; CVD, cardiovascular disease; IHD, ischemic heart disease; HHF, hypertensive heart failure; ESRD, end-stage renal disease. Q1, poorest quintile; Q5, wealthiest quintile.
*Death rate ranges reflect the highest and lowest death rate used for any of the five quintiles.